Publications by authors named "Paul R Sebahar"

Claim this Profile
comparison of V.A.C.® Granufoam Silver™ and V.A.C.® Granufoam™ loaded with a first-in-class bis-dialkylnorspermidine-terphenyl antibiofilm agent.
Kaden B Rawson, Travis Neuberger, Tyler B Smith, Isaac J Bell, Ryan E Looper, Paul R Sebahar

Biofilm· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiofilm potential of a negative pressure wound therapy foam loaded with a first-in-class tri-alkyl norspermidine-biaryl antibiotic.
Kaden B Rawson, Travis Neuberger, Tyler Smith, Hariprasada Reddy Kanna Reddy, Travis J Haussener, Paul R Sebahar

J Biomed Mater Res B Appl Biomater· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
efficacy of a unique first-in-class antibiofilm antibiotic for biofilm-related wound infections caused by .
Dustin L Williams, Brooke Kawaguchi, Nicholas B Taylor, Gina Allyn, Marissa A Badham, Paul R Sebahar

Biofilm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms.
Mariël Miller, Jeffery C Rogers, Marissa A Badham, Lousili Cadenas, Eian Brightwell, Paul R Sebahar

PLoS One· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unifying the Aminohexopyranose- and Peptidyl-Nucleoside Antibiotics: Implications for Antibiotic Design.
Catherine M Serrano, Hariprasada Reddy Kanna Reddy, Daniel Eiler, Michael Koch, Ben I C Tresco, Paul R Sebahar

Angew Chem Int Ed Engl· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo analysis of a first-in-class tri-alkyl norspermidine-biaryl antibiotic in an active release coating to reduce the risk of implant-related infection.
Dustin L Williams, Richard T Epperson, Nicholas N Ashton, Nicholas B Taylor, Brooke Kawaguchi, Paul R Sebahar

Acta Biomater· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro testing of a first-in-class tri-alkylnorspermidine-biaryl antibiotic in an anti-biofilm silicone coating.
Nicholas N Ashton, Gina Allyn, Scott T Porter, Travis J Haussener, Paul R Sebahar

Acta Biomater· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.
Kristjan S Gudmundsson, Paul R Sebahar, Leah D'Aurora Richardson, John F Miller, Elizabeth M Turner

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydrocarbazole amides with potent activity against human papillomaviruses.
Kristjan S Gudmundsson, Sharon D Boggs, Paul R Sebahar, Leah D'Aurora Richardson, Andrew Spaltenstein

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted tetrahydrocarbazoles with potent activity against human papillomaviruses.
Kristjan S Gudmundsson, Paul R Sebahar, Leah D'Aurora Richardson, John G Catalano, Sharon D Boggs

Bioorg Med Chem Lett· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise, asymmetric total synthesis of spirotryprostatin A.
Tomoyuki Onishi, Paul R Sebahar, Robert M Williams

Org Lett· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis